References
Medical articles pertaining to specific conditions in wrestling.
Tinea Corporis Gladiatorum
Adams B. Tinea corporis gladiatorum: A cross-sectional study. J Am Acad Derm 2000;43(6):1039-41.
Beller M, Gessner BD. An outbreak of Tinea Corporis Gladiatorum on a high school wrestling team. J Am Acad Derm 1994;31:197-201.
Hand JW, Wroble RR. Prevention of Tinea Corporis in Collegiate Wrestlers. J Ath Train.1999;34(4):350-52.
Hazen PG, Weil ML. Itraconazole in the prevention and management of dermatophytosis in competitive wrestlers. J Am Acad Derm 1997;36:481-82.
Hradil E, et. al. An Epidemic of Tinea Corporis Caused by Trichophyton tonsurans among Wrestlers in Sweden. Acta Derm Venereol 1995;75:305-6.
Stiller MJ, et.al. Tinea corporis gladiatorum: An epidemic of Trichophyton tonsurans in student wrestlers. J Am Acad Derm 1992;27:632-3.
Kohl TD, Martin DC, Nemeth R, Hill T, Evans D. Fluconazole for the prevention and treatment of tinea gladiatorum. Pediatr Infect Dis J, 2000;19:717-22.
Kohl TD, Lisney M. Tinea Gladiatorum, Wrestling’s Emerging Foe. Sports Med 2000, Jun 29(6):439-47.
Kohl TD, Martin D, Berger MS. Comparison of Topical and Oral Treatments for Tinea Gladiatorum. Clin J Sports Med. 1999; 9(3):161-6.
Stiller MJ, et.al. Tinea corporis gladiatorum: An epidemic of Trichophyton tonsurans in student wrestlers. J Am Acad Derm 1992;27:632-3.
Brickman K, Einstein E, Sinha S, Ryno J, Guiness M. Fluconazole As a Prophylactic Measure for Tinea Gladiatorum in High School Wrestlers. Clin J Sports Med. 2009;19(5):412-14.
Beller M, Gessner BD. An outbreak of Tinea Corporis Gladiatorum on a high school wrestling team. J Am Acad Derm 1994;31:197-201.
Hand JW, Wroble RR. Prevention of Tinea Corporis in Collegiate Wrestlers. J Ath Train.1999;34(4):350-52.
Hazen PG, Weil ML. Itraconazole in the prevention and management of dermatophytosis in competitive wrestlers. J Am Acad Derm 1997;36:481-82.
Hradil E, et. al. An Epidemic of Tinea Corporis Caused by Trichophyton tonsurans among Wrestlers in Sweden. Acta Derm Venereol 1995;75:305-6.
Stiller MJ, et.al. Tinea corporis gladiatorum: An epidemic of Trichophyton tonsurans in student wrestlers. J Am Acad Derm 1992;27:632-3.
Kohl TD, Martin DC, Nemeth R, Hill T, Evans D. Fluconazole for the prevention and treatment of tinea gladiatorum. Pediatr Infect Dis J, 2000;19:717-22.
Kohl TD, Lisney M. Tinea Gladiatorum, Wrestling’s Emerging Foe. Sports Med 2000, Jun 29(6):439-47.
Kohl TD, Martin D, Berger MS. Comparison of Topical and Oral Treatments for Tinea Gladiatorum. Clin J Sports Med. 1999; 9(3):161-6.
Stiller MJ, et.al. Tinea corporis gladiatorum: An epidemic of Trichophyton tonsurans in student wrestlers. J Am Acad Derm 1992;27:632-3.
Brickman K, Einstein E, Sinha S, Ryno J, Guiness M. Fluconazole As a Prophylactic Measure for Tinea Gladiatorum in High School Wrestlers. Clin J Sports Med. 2009;19(5):412-14.
Herpes Gladiatorum
Anderson BJ, McGuire D, Reed M, Foster M, Ortiz D. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-day wrestling camp- a 10-year review. Clin J Sports Med. 2016.26(4):272-8.
Anderson BJ. Managing Herpes Gladiatorum Outbreaks in Competitive Wrestling: The 2007 Minnesota Experience. Curr Sports Med. Rep.2008;7(6):323-327.
Anderson BJ. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-day wrestling camp. Jap J Inf Dis.2006;59:6-9.
Anderson BJ. Valacyclovir to Expedite the Clearance of Recurrent Herpes Gladiatorium. Clin J Sports Med. 2005;5:264-6.
Anderson BJ. The Epidemiology and Clinical Analysis of Several Outbreaks of Herpes Gladiatorum. Med Sci Sports Exerc. 2003-11-6, 35(11);1809-14.
Anderson BJ, Clark A, Tillman D. Valacyclovir for Prevention of Reactivation of Herpes Gladiatorum in Wrestlers: an Updated Study. Am J of Med & Sports. 2003;5:309-14.
Anderson BJ. The Effectiveness of Valacyclovir in Preventing Reactivation of Herpes Gladiatorum in Wrestlers. Clin J Sports Med.1999;2:86-90.
Becker TM, et. al. Grappling with herpes: Herpes Gladiatorum. Am J Sports Med 1988;16:665-69.
Belongia EA, et.al. An Outbreak of Herpes Gladiatorum at a high school Wrestling Camp. N Engl J Med 1991;325:906-10.
Selling B, Kibrick S. An Outbreak of Herpes Simplex Among Wrestlers (Herpes Gladiatorum). N Eng J Med 1964;270:979-82.
Anderson BJ. Managing Herpes Gladiatorum Outbreaks in Competitive Wrestling: The 2007 Minnesota Experience. Curr Sports Med. Rep.2008;7(6):323-327.
Anderson BJ. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-day wrestling camp. Jap J Inf Dis.2006;59:6-9.
Anderson BJ. Valacyclovir to Expedite the Clearance of Recurrent Herpes Gladiatorium. Clin J Sports Med. 2005;5:264-6.
Anderson BJ. The Epidemiology and Clinical Analysis of Several Outbreaks of Herpes Gladiatorum. Med Sci Sports Exerc. 2003-11-6, 35(11);1809-14.
Anderson BJ, Clark A, Tillman D. Valacyclovir for Prevention of Reactivation of Herpes Gladiatorum in Wrestlers: an Updated Study. Am J of Med & Sports. 2003;5:309-14.
Anderson BJ. The Effectiveness of Valacyclovir in Preventing Reactivation of Herpes Gladiatorum in Wrestlers. Clin J Sports Med.1999;2:86-90.
Becker TM, et. al. Grappling with herpes: Herpes Gladiatorum. Am J Sports Med 1988;16:665-69.
Belongia EA, et.al. An Outbreak of Herpes Gladiatorum at a high school Wrestling Camp. N Engl J Med 1991;325:906-10.
Selling B, Kibrick S. An Outbreak of Herpes Simplex Among Wrestlers (Herpes Gladiatorum). N Eng J Med 1964;270:979-82.
Impetigo, cellulitis, folliculitis, CA-MRSA
Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcal aureus-Minnesota and North Dakota, 1997-1999. JAMA. 1999;282:1123-5.
Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis. 1993;17:466-74.
Epstein ME, et.al. Antimicrobial agents for the dermatologist. I. Beta lactam antibiotics and related compounds. J Am Acad Derm 1997;37:149-65.
Epstein ME, et.al. Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin. J Am Acad Derm 1997;37:365-81.
Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-Resistant Staphylococcus aureus Disease in Three Communities. New Engl J Med. 2005;352(14):1436-44.
Hageman JC, Uyeki TM, Francis JS, et al. Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003-04 Influenza Season. Emerg Infect Dis. 2006;12(6):894-9.
Jimenez-Truque N, et al. Longitudinal Assessment of Colonization with Staphylococcus aureus in Health Collegiate Athletes. J Ped Inf Disease Soc. 2014;5(2):105-13.
Karanika S, Kinamon T, Grigoras C, Mylonakis E. Colonization With Methicillin-resistant Staphylococcus aureus and Risk for Infection Among Asymptomatic Athletes: A Systematic Review and Metaanalysis. CID.2016;63 (15 July);195-204.
Kazakova SV, Hageman JC, Matava M, et al. A Clone of Methicillin-Resistant Staphylococcus aureus among Professional Players. New Engl J Med. 2005;352(5): 468-475.
Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. New Engl J Med. 2006;355(7): 666-674.
Naimi TS, LeDell K, Como-Sabetti K, et al. Comparison of Community-and Health Care-Associated Methicillin-Resistant Staphylococcus aureus Infection. JAMA 2003;290:2976-84.
Nguyen DM, Mascola L, Bancroft E. Recurring Methicillin-resistant Staphylococcus aureus Infections in a Football Team. Emerg Infect Dis. 2005;11(4);526-32.
Rasmussen JE. Treatment of Nasal Carriage of Staphylococcus Aureus. In: Aly R, Beutner KR, Maibach H, editors. Cutaneous Infection and Therapy. New York: Marcel Dekker, Inc.; 1997. p.25-8.
Romano R, Doanh L, Holtom P. Outbreak of Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin Infections Among Collegiate Football Team. J Athl Train. 2006;41(2):141-5.
Sadick NS. Current Aspects of Bacterial Infections of the Skin. Dermatologic Clinics 1997;15:341-49.
Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis. 1993;17:466-74.
Epstein ME, et.al. Antimicrobial agents for the dermatologist. I. Beta lactam antibiotics and related compounds. J Am Acad Derm 1997;37:149-65.
Epstein ME, et.al. Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin. J Am Acad Derm 1997;37:365-81.
Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-Resistant Staphylococcus aureus Disease in Three Communities. New Engl J Med. 2005;352(14):1436-44.
Hageman JC, Uyeki TM, Francis JS, et al. Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003-04 Influenza Season. Emerg Infect Dis. 2006;12(6):894-9.
Jimenez-Truque N, et al. Longitudinal Assessment of Colonization with Staphylococcus aureus in Health Collegiate Athletes. J Ped Inf Disease Soc. 2014;5(2):105-13.
Karanika S, Kinamon T, Grigoras C, Mylonakis E. Colonization With Methicillin-resistant Staphylococcus aureus and Risk for Infection Among Asymptomatic Athletes: A Systematic Review and Metaanalysis. CID.2016;63 (15 July);195-204.
Kazakova SV, Hageman JC, Matava M, et al. A Clone of Methicillin-Resistant Staphylococcus aureus among Professional Players. New Engl J Med. 2005;352(5): 468-475.
Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. New Engl J Med. 2006;355(7): 666-674.
Naimi TS, LeDell K, Como-Sabetti K, et al. Comparison of Community-and Health Care-Associated Methicillin-Resistant Staphylococcus aureus Infection. JAMA 2003;290:2976-84.
Nguyen DM, Mascola L, Bancroft E. Recurring Methicillin-resistant Staphylococcus aureus Infections in a Football Team. Emerg Infect Dis. 2005;11(4);526-32.
Rasmussen JE. Treatment of Nasal Carriage of Staphylococcus Aureus. In: Aly R, Beutner KR, Maibach H, editors. Cutaneous Infection and Therapy. New York: Marcel Dekker, Inc.; 1997. p.25-8.
Romano R, Doanh L, Holtom P. Outbreak of Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin Infections Among Collegiate Football Team. J Athl Train. 2006;41(2):141-5.
Sadick NS. Current Aspects of Bacterial Infections of the Skin. Dermatologic Clinics 1997;15:341-49.
Miscellaneous
Anderson BJ. Effectiveness of Body Wipes as an Adjunct to Reducing Skin Infections in High School Wrestlers. Clin J Sports Med. 2012;5: 4-9.
Anderson BJ. Skin Infections in Minnesota High School State Tournament Wrestlers: 1997-2006. Clin J Sports Med.2007;17:478-480.
Anderson BJ. Skin Infections in Combat Sports. In Kordi R, Maffulli N, Wrobble R and Wallace W. (eds): Combat Sports Medicine. Secaucus, NJ: Springer,2009:121-133.
Ashack K, et al. Skin infections among US high school athletes: A national survey. J Am Acad Dermatol. 2016.74(4);679-84.
Hammer K, Carson C, Riley T, Nielsen J. A review of Melaleuca alternifolia (tea tree) oil. Food Chem Toxic.2006; 44(5):616-25.
Hendrickson MA, Furnival RM, Anderson BJ, Renaker AM, Gaillard PR, Roback MG. Emergency Department Usage and Medical Care Needs of Adolescent Participants in a High-Intensity Wrestling Camp. Sports Health. 2012;3:258-60.
Pecci M, Coneau D, Chaula V. Skin Conditions in the Athlete. Am J Sports Med. 2009;37(2):406-18.
Whitman T, et al. Chlorhexidine-Impregnated Cloths to Prevent Skin and Soft-Tissues in Marine Recruits: A Cluster-Randomized, Double-Blind, Controlled Effectiveness Trial. Inf Control Hospit Epid. 2010;31(12):1207-15.
Yard E, Collins C, Dick R, Comstock D. An Epidemiologic Comparison Of High School and College Wrestling Injuries. Am J Sports Med. 2008.36(1);57-64.
Young L, Motz V, Markey E, Young S, Beaschler R. Recommendations for best practices to reduce the spread of infections via wrestling mats. 2017.J Athl Train;2017:52(2);82-88.
Anderson BJ. Skin Infections in Minnesota High School State Tournament Wrestlers: 1997-2006. Clin J Sports Med.2007;17:478-480.
Anderson BJ. Skin Infections in Combat Sports. In Kordi R, Maffulli N, Wrobble R and Wallace W. (eds): Combat Sports Medicine. Secaucus, NJ: Springer,2009:121-133.
Ashack K, et al. Skin infections among US high school athletes: A national survey. J Am Acad Dermatol. 2016.74(4);679-84.
Hammer K, Carson C, Riley T, Nielsen J. A review of Melaleuca alternifolia (tea tree) oil. Food Chem Toxic.2006; 44(5):616-25.
Hendrickson MA, Furnival RM, Anderson BJ, Renaker AM, Gaillard PR, Roback MG. Emergency Department Usage and Medical Care Needs of Adolescent Participants in a High-Intensity Wrestling Camp. Sports Health. 2012;3:258-60.
Pecci M, Coneau D, Chaula V. Skin Conditions in the Athlete. Am J Sports Med. 2009;37(2):406-18.
Whitman T, et al. Chlorhexidine-Impregnated Cloths to Prevent Skin and Soft-Tissues in Marine Recruits: A Cluster-Randomized, Double-Blind, Controlled Effectiveness Trial. Inf Control Hospit Epid. 2010;31(12):1207-15.
Yard E, Collins C, Dick R, Comstock D. An Epidemiologic Comparison Of High School and College Wrestling Injuries. Am J Sports Med. 2008.36(1);57-64.
Young L, Motz V, Markey E, Young S, Beaschler R. Recommendations for best practices to reduce the spread of infections via wrestling mats. 2017.J Athl Train;2017:52(2);82-88.